Interestingly, the inhibition of the WNT pathway increases the expression of SQSTM1 in glioblastoma cells and sensitizes the tumor cells to the autophagy inhibitor effects, and therefore could offer an alternative therapy [125]. This evidence concerns the gene SQSTM1 and glioblastoma.